Abstract: Disclosed are a battery power control device, a portable device and a method of controlling the portable device. The disclosed portable device includes a workload calculator which calculates a workload necessary to provide the specific service to the user according to at least one of time request information related to a desired time during which the specific service is provided to the user and QoS (Quality of Service) request information related to a quality of the specific service, the necessary workload being smaller than a default workload that is preset for providing the specific service; a task performer which performs a task for providing the specific service according to the necessary workload during a time that is reduced to be shorter than a task performance time according to the default workload and stop the task performance during the reduced time; and a battery unit which supplies a power for performing the task to the task performer.

Abstract: The present invention relates generally to the use of circulating cytochrome c as a biomarker of reperfusion injury that results from whole body ischemia. Circulating levels of cytochrome c can be used as predictor of survival rates and to assess the effects of interventions aimed at ameliorating mitochondrial injury during reperfusion. Whole body ischemia may be the result of cardiac arrest or from other hemodynamic crises, such as hemorrhagic shock.

Abstract: Medical device or instrument for diagnosing pressure ulcers using optical reflectance spectroscopy. The device may comprise a tip and a controller. The tip is pressed against the skin of the patient and collects the optical reflectance data. The controller processes the data to determine whether there exists a pressure ulcer and, if there is one, its depth. The tip may also include a pressure sensor for sensing the pressure at which the tip is applied to the patient's skin.

Abstract: The present invention provides methods for reducing or inhibiting angiogenesis in a tissue, by contacting ?5?1 integrin in the tissue with an agent that interferes with specific binding of the ?5?1 integrin to a ligand expressed in the tissue. The invention further provides methods of reducing or inhibiting angiogenesis in a tissue in an individual, by administering to the individual an agent that interferes with the specific binding of ?5?1 integrin to a ligand expressed in the tissue; and methods of reducing the severity of a pathological condition associated with angiogenesis in an individual, by administering to the individual an agent that interferes with specific binding of ?5?1 integrin to a ligand in a tissue associated with the pathological condition.

Abstract: The present disclosure relates to a transparent polyarylene ether polymer with high heat resistance and a method for preparing the same. More particularly, the present disclosure relates to a polyarylene ether polymer and a method for preparing the same, wherein the polyarylene ether polymer has a repeating structure in which cardo-type aromatic diols having a large molecular volume, polyether sulfones which are amorphous polymers having a high glass transition temperature and superior film formability, and polyether ketones which are crystalline polymers having superior heat resistance and mechanical properties are sequentially arranged. The polyarylene ether polymer is both transparent and heat resistant and, thus, can be used, for example, for a flexible plastic substrate.

Abstract: Embodiments of wearable flexible devices and related methods are described herein. Other embodiments and related methods are also disclosed herein.

Abstract: Compositions which comprise emulsions of nanoparticles for delivery of membrane-integrating peptides are described. The nanoparticles comprise a liquid hydrophobic core coated with a lipid/surfactant layer which contains the membrane-integrating peptides. Methods to use such compositions are also described.

Abstract: The present invention provides methods for determining a putative agent that treats or prevent obesity and/or obesity related diseases comprising contacting cells with the putative agent and measuring the activity and/or level of Maf1 and/or the activity and/or level of KIAA1875. The present invention also provides the agent identified by the methods herein and methods of treating or preventing obesity and/or obesity related diseases in a subject comprising administering to the subject a therapeutically effective amount of an agent that inhibits or downregulates Maf1 and/or activates or upregulates KIAA1875.

Abstract: The present invention is directed to methods of using a sirolimus drug and chloroquine or a quinoline derivative in combination. Methods of use are also described.

Abstract: Measurement of the optical point spread function through a double-pass technique is enhanced by using adaptive optics to form a tiny spot of light on the retina.

Abstract: An optical coherence tomography scanning system includes a lens divided into two halves: one optimized to achieve normal incidence angles on the posterior surface of the eye's lens, the other optimized for the anterior surface of the eye's lens.

Abstract: The present invention provides methods of identifying subjects that are suitable for high-dose cyclophosphamide treatment.

Abstract: The combination of the surfactant SDS with levulinic acid produces a synergistic effect in relation to the antimicrobial effectiveness of the individual compounds. Accordingly, this surprising synergy allows the formulation of compositions wherein the active agents are present at concentrations effective to reduce bacterial counts in liquids, including, but not limited to, water and other beverages, especially those having a pH value less than about 7.0 by a factor between 103 and 107 without altering the organoleptic properties of the treated food substance. The active agents are FDA-approved as food additives, and the treated beverages can be any aqueous-based beverage consumable by humans or animals.

Abstract: A method for producing fluorapatite and its application are disclosed in the present invention, which relates to the field of biomaterials for dental reparation. The present invention comprises steps of mixing tetracalcium phosphate, calcium hydrogen phosphate, and sodium fluoride to form a mixture and adding the mixture into water, or mixing tetracalcium phosphate and ammonium fluoride to form a mixture and then adding the mixture into a phosphoric acid/water solution, blending the above two sets of materials respectively to form cement-like substances; and solidifying the cement-like substances at a temperatures of 35° C. to 38° C. and a moisture of 100% for 1-3 days to produce fluorapatite. The synthesized fluorapatite has a similar chemical composition with tooth enamel, thus, the fluorapatite produced by the invention can be combined with the natural enamel directly, so as to repair enamel defects caused by caries, especially severe enamel defects (deep caries).

Abstract: A method for data encoding and associated decoding is based on the concept of batches that allows transmission of a large data file from a source node to multiple destination nodes through communication networks that may employ network coding wherein sparse matrix codes are employed in a network setting. A batch is a set of packets generated by a subset of the input packets using sparse matrix encoder. A sparse matrix encoder can be called repeatedly to generate multiple batches. The batches are generally independent of one another. During the transmission in a communication network, network coding can be applied to packets belonging to the same batch to improve the multicast throughput. A decoder recovers all or at least a fixed fraction of the input packets using received batches. The input packets can be pre-coded using a pre-code before applying sparse matrix codes. The data file can then be reconstructed by further decoding the pre-code.

Abstract: An observation system for viewing light-sensitive tissue includes an illumination system configured to illuminate the light-sensitive tissue, an imaging system configured to image at least a portion of the light-sensitive tissue upon being illuminated by the illumination system, and an image display system in communication with the imaging system to display an image of the portion of the light-sensitive tissue.

Abstract: Disclosed herein are manganese, iron, cobalt, or nickel complexes containing 2,8-bis(imino)quinoline ligands and their use as catalysts or catalysts precursors for hydrosilylation reactions.

Abstract: Disclosed are methods of protecting cells, especially non-vascular system, non-hematopoietic cells and tissues, from apoptosis and enhancing their engraftment, survival, and/or persistence by providing enhanced levels of PIM activity for the cell, including PIM-1 activity. Also disclosed are cells that have been engineered to express enhanced levels of PIM kinase, and methods of administering those cells to vertebrates.

Abstract: This invention relates to optomechanical systems and methods for altering, modifying or disrupting a target object. Such systems and methods are used for, for example, ablating the endogenous nucleus in a cell.

Abstract: The present invention relates to methods of treating an autoimmune disorder, using a lymphocytotoxic but hematopoeitic cell sparing high-dose pulsed amount of an oxazaphosphorine drug in combination with immune therapeutics such as, for example, monoclonal antibodies that selectively bind B-cell specific antigens.